Emerson’s Herkt: Where Is the “Burning Ambition” for PAT/QbD?
Pharma can do better, says Emerson Process Management COO Melissa Herkt. We need a “burning ambition” for PAT to take hold and for change to take place, and that ambition must start with inspirational...
View ArticleMcKinsey’s Ulf Schrader on Toyota and Quality Lessons for Pharma
Design to Quality...presents industry with a $20-to-$30-billion opportunity to optimize technical development. And that’s just on the cost side, without even considering the customer preference angle....
View ArticleAli Afnan: Bridging Pharma’s Innovation Divide
Could closer study of Lean performance, supplement approval, and GMP oversight reveal correlations and drive holistic innovation, and cultural change?
View Article“Making the Routine Routine”: The Key to Sustaining Manufacturing Improvement
In this new video, Catalent VP of Operations Mark Dean-Netscher maps out a mechanistic approach to operational excellence and continuous improvement.
View ArticleApril in Bethesda: FDA, Thought Leaders to Discuss QbD and What Lies Ahead
This accredited, NIPTE-sponsored event features QbD thought leaders representing FDA, industry, academia, consultancies, and solution providers.
View ArticleDrug Manufacturing: Still Waiting for the Sea Change?
Pharmaceutical Manufacturing's April cover story asks the question, have we made real and tangible progress in the past decade?
View Article
